Money Concepts Capital Corp Glaukos Corp Transaction History

Money Concepts Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$59.53 - $85.11 $230,678 - $329,801	3,875 Added 2.42%	163,969 $13 Million
Q3 2023 Oct 31, 2023	BUY	$69.23 - $79.09 $810,406 - $925,827	11,706 Added 7.89%	160,094 $12 Million
Q2 2023 Jul 31, 2023	BUY	$45.44 - $71.21 $6.74 Million - $10.6 Million	148,388 New	148,388 $10.6 Million
Q2 2022 Jul 18, 2022	SELL	$34.86 - $63.77 $3,486 - $6,377	-100 Reduced 50.0%	100 $5,000
Q1 2022 May 13, 2022	BUY	$44.33 - $57.82 $8,866 - $11,564	200 New	200 $12,000

351

55.3M

163K

458K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.29B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.